Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 3.73 is 15% above its 5-year average of 3.23, near the high end of its 5-year range (2.68–3.75).
As of the fiscal period ended Friday, April 24, 2026. 1.08% above its 12-month average of 3.69.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
3.73
EARNINGS PER SHARE (EPS) AVG TTM
3.69
EARNINGS PER SHARE (EPS) AVG 3Y
3.25
EARNINGS PER SHARE (EPS) AVG 5Y
3.23
EARNINGS PER SHARE (EPS) AVG 10Y
3.10
EARNINGS PER SHARE (EPS) AVG 15Y
3.08
EARNINGS PER SHARE (EPS) AVG 20Y
2.88
CURRENT VS TTM AVG
+1.08%
CURRENT VS 3Y AVG
+14.95%
CURRENT VS 5Y AVG
+15.30%
CURRENT VS 10Y AVG
+20.18%
CURRENT VS 15Y AVG
+20.96%
CURRENT VS 20Y AVG
+29.45%
Medtronic plc
Market Cap
$111.21B
Earnings Per Share (EPS)
3.73
TTM Avg
3.69
3Y Avg
3.25
5Y Avg
3.23
Market Cap
$104.14B
Earnings Per Share (EPS)
38.47
TTM Avg
32.20
3Y Avg
28.04
5Y Avg
15.41
Market Cap
$124.46B
Earnings Per Share (EPS)
16.86
TTM Avg
6.69
3Y Avg
10.10
5Y Avg
9.99
Market Cap
$127.82B
Earnings Per Share (EPS)
8.79
TTM Avg
7.27
3Y Avg
5.84
5Y Avg
5.20
Market Cap
$92.77B
Earnings Per Share (EPS)
29.08
TTM Avg
25.45
3Y Avg
22.39
5Y Avg
20.36
Market Cap
$129.88B
Earnings Per Share (EPS)
3.56
TTM Avg
-0.48
3Y Avg
1.47
5Y Avg
0.84
Market Cap
$132.87B
Earnings Per Share (EPS)
8.64
TTM Avg
8.18
3Y Avg
7.73
5Y Avg
6.75
Market Cap
$133.67B
Earnings Per Share (EPS)
13.28
TTM Avg
11.14
3Y Avg
8.54
5Y Avg
6.53
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medtronic plc (MDT) | $111.21B | 3.73 | 3.69 | 3.25 | 3.23 |
| GSK plc (GSK)vs › | $108.36B | 4.52 | 4.58 | 5.32 | 4.82 |
| McKesson Corporation (MCK)vs › | $104.14B | 38.47 | 32.20 | 28.04 | 15.41 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $124.46B | 16.86 | 6.69 | 10.10 | 9.99 |
| Intuitive Surgical, Inc. (ISRG)vs › | $127.82B | 8.79 | 7.27 | 5.84 | 5.20 |
| HCA Healthcare, Inc. (HCA)vs › | $92.77B | 29.08 | 25.45 | 22.39 | 20.36 |
| Bristol-Myers Squibb Company (BMY)vs › | $129.88B | 3.56 | -0.48 | 1.47 | 0.84 |
| Stryker Corporation (SYK)vs › | $132.87B | 8.64 | 8.18 | 7.73 | 6.75 |
| AstraZeneca PLC (AZN)vs › | $133.67B | 13.28 | 11.14 | 8.54 | 6.53 |
| Elevance Health Inc. (ELV)vs › | $83.65B | 22.50 | 25.49 | 25.23 | 24.07 |
Trailing EPS (TTM)
$3.73
Forward EPS (Est.)
$5.52
P/E Ratio
22.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-04-24 | 3.75 |
| 2025-04-30 | 3.63 |
| 2024-04-30 | 2.77 |
| 2023-04-30 | 2.83 |
| 2022-04-30 | 3.75 |
| 2021-04-30 | 2.68 |
| 2020-04-30 | 3.57 |
| 2019-04-30 | 3.44 |
| 2018-04-30 | 2.29 |
| 2017-04-30 | 2.92 |
| 2016-04-30 | 2.51 |
| 2015-04-30 | 2.44 |
| 2014-04-30 | 3.06 |
| 2013-04-30 | 3.40 |
| 2012-04-30 | 3.43 |
| 2011-04-30 | 2.87 |
| 2010-04-30 | 2.80 |
| 2009-04-30 | 1.85 |
| 2008-04-30 | 1.97 |
| 2007-04-30 | 2.44 |
| 2006-04-30 | 2.11 |
| 2005-04-30 | 1.49 |
| 2004-04-30 | 1.61 |
| 2003-04-30 | 1.31 |
| 2002-04-30 | 0.81 |
| 2001-04-30 | 0.87 |
| 2000-04-30 | 0.91 |
| 1999-04-30 | 0.40 |
| 1998-04-30 | 0.52 |
| 1997-04-30 | 0.51 |
